miRagen Therapeutics announces common stock offering

|By:, SA News Editor

miRagen Therapeutics (NASDAQ:MGEN) intends to offer for sale 7M shares of its common stock in a public offering.

Underwriters are granted a 30-day option to purchase up to an additional 1,050,000 shares.

Net proceeds will be used for working capital and general corporate purposes, including the funding of clinical development of its product candidates.

Shares are down 1%  premarket on light volume.

Subscribe for full text news in your inbox